MQ-Nate Injection
Marketer
Mediquest Inc.
Salt Composition
Artesunate (60mg)
Overview MQ-Nate Injection
Natequine Injection combats parasitic infections, specifically malaria. This injectable medication treats malaria but is not a preventative measure nor suitable for severe cases affecting vital organs such as the brain, lungs, or kidneys. Administration must be performed by a healthcare provider; self-injection is strictly prohibited and reserved for situations where oral administration is infeasible. Potential side effects include headache, dizziness, fatigue, and decreased appetite. Local injection site reactions, such as pain, swelling, or inflammation, are also possible. Persistent side effects warrant immediate medical attention. Post-treatment, regular blood tests (weekly for four weeks) may be conducted to monitor for residual malarial parasites.
Primary Ingredients of MQ-Nate Injection
No text was provided to rewrite.
Uses of MQ-Nate Injection
Plasmodium infection
Major Benefits of MQ-Nate Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of MQ-Nate Injection:
- Headache
- Dizziness
- Weakness
- Loss of appetite
- Injection site reactions (pain, swelling, redness)
How to use MQ-Nate Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strongly discouraged.
How MQ-Nate Injection works:
MQ-Nate Injection is an antiparasitic drug that eliminates malarial parasites by generating cytotoxic free radicals within the parasite itself.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside MQ-Nate Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of MQ-Nate Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of MQ-Nate Injection while breastfeeding appears to pose minimal risk. Available data from human studies indicate an insignificant threat to the infant.
DrivingUNSAFE
Administering MQ-Nate Injection might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of MQ-Nate Injection in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding MQ-Nate Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take MQ-Nate Injection :
Omit a dose of MQ-Nate Injection? Seek medical advice immediately.
Facts to Know About MQ-Nate Injection
| Label | Value |
|---|---|
| Chemical Category | Sesquiterpene lactones |
| Developing Habits | No. |
| Treatment Category | Antimalarial Medications |
| Behavior Class | Artemisinin-based antimalarials |
3,018 People bought this recently